Porcilis AR-T DF

RSS

adjuvanted vaccine against progressive atrophic rhinitis in piglets

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 05/05/2014

Authorisation details

Product details
Name
Porcilis AR-T DF
Agency product number
EMEA/V/C/000055
Active substance
  • protein dO (non-toxic deletion derivative of Pasteurella multocida dermonecrotic toxin)
  • inactivated Bordetella bronchiseptica cells
International non-proprietary name (INN) or common name
adjuvanted vaccine against progressive atrophic rhinitis in piglets
Species
Pigs (gilts and sows)
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AB04
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
16/11/2000
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

25/04/2014 Porcilis AR-T DF - EMEA/V/C/000055 - IB/0013

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

For the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.

Assessment history

How useful was this page?

Add your rating